FreeStyle Libre 3 Continuous Glucose Monitoring System— 510(k) K212132
Substantially EquivalentAbbott Diabetes Care, Inc.
FDA 510(k) clearance K212132 for FreeStyle Libre 3 Continuous Glucose Monitoring System, Substantially Equivalent on 2022-05-26. Applicant: Abbott Diabetes Care, Inc..
Clearance details
- Applicant
- Abbott Diabetes Care, Inc.
- Product code
- Code QLG
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Alameda, CA, US
Adverse events under product code QLG
product code QLG- Death
- 27
- Injury
- 40,773
- Malfunction
- 107,857
- Other
- 6
- Total
- 148,663
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.